Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort

(2012) J Cuzick et al.   BRITISH JOURNAL OF CANCER

THE JAMES LIND ALLIANCE APPROACH TO PRIORITY SETTING FOR PROSTATE CANCER RESEARCH: AN INTEGRATIVE METHODOLOGY BASED ON PATIENT AND CLINICIAN PARTICIPATION

(2011) Artitaya Lophatananon et al.   BJU INTERNATIONAL

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies

(2011) S Fasanella et al.   Diagnostic Pathology

Diagnostic and prognostic molecular biomarkers for prostate cancer

(2011) Glen Kristiansen   HISTOPATHOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

(2011) Jack Cuzick et al.   LANCET ONCOLOGY

Expression of Bcl-2, p53, and MDM2 in Localized Prostate Cancer With Respect to the Outcome of Radical Radiotherapy Dose Escalation

(2010) Roy Vergis et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

High-density tissue microarrays from prostate needle biopsies

(2010) F. McCarthy et al.   JOURNAL OF CLINICAL PATHOLOGY

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study

(2009) D M Berney et al.   BRITISH JOURNAL OF CANCER

MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02

(2009) Li-Yan Khor et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer

(2008) Tobias Zellweger et al.   INTERNATIONAL JOURNAL OF CANCER

Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance

(2008) S Jhavar et al.   PROSTATE CANCER AND PROSTATIC DISEASES

p53 Protein Expression Status and Recurrence in Men Treated with Radiation and Androgen Suppression Therapy for Higher-Risk Prostate Cancer: A Prospective Phase II Cancer and Leukemia Group B Study (CALGB 9682)

(2008) Anthony V. D'Amico et al.   UROLOGY

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

(2008) Sven Gunia et al.   WORLD JOURNAL OF UROLOGY